Analysis on the effects of health function food in Ceriporia Lacerata on the managemenet of chronic complications in type 2 diabetes patients: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006233

Enrollment

Registered

2021-06-09

Start date

2019-09-10

Completion date

Unknown

Last updated

2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. During the 12-week intervention period, subjects were asked to take two capsules (500?mg/capsule) of Ceriporia Lacerata mycelium or a placebo three times a day preferably before every meal.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - korean adult aged above 19years - more than 6 months have passed since diagnosed with type 2 diabetes mellitus, and taking oral hypoglycemic agents - Hba1c checked 7..0~9% in past 4 weeks - patients agreed on paper to sign in the study - patients who are able to be traced

Exclusion criteria

Exclusion criteria: - pregnant or breast feeding women - patients diagnosed with severe liver disease, biliary tract obstruction or AST/ALT higher than 5 times normal range - patients diagnosed with severe kidney disease (eGFR<30%) - Hba1c above 10% - patients with lactose intolerance - psychotic or who are not able to understand the purpose of this study - peopole who can't read or foreigners whot can't read the informed aggrement - patient who disagreed to write the agreement or who doesn't want to sign in the study

Design outcomes

Primary

Measure	Time frame
Insulin resistance	—

Secondary

Measure	Time frame
fasting glucose	—

Countries

Korea, Republic of

Contacts

Public ContactJi sun Nam

Yonsei University Health System, Gangnam Severance Hospital

jisunn@yuhs.ac+82-2-2019-4370

Outcome results